• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性高盐皮质激素状态下心脏纤维化的决定因素。

Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.

作者信息

Young M, Head G, Funder J

机构信息

Baker Medical Research Institute, Prahran, Victoria, Australia.

出版信息

Am J Physiol. 1995 Oct;269(4 Pt 1):E657-62. doi: 10.1152/ajpendo.1995.269.4.E657.

DOI:10.1152/ajpendo.1995.269.4.E657
PMID:7485478
Abstract

Uninephrectomized rats maintained on 1.0% NaCl to drink and infused with aldosterone (0.75 microgram/h) for 8 wk have previously been shown to develop hypertension, cardiac hypertrophy, and cardiac fibrosis. In the present study we have shown that K+ supplementation (1.0% NaCl plus 0.4% KCl drinking solution) alters neither the interstitial nor the perivascular fibrotic response to mineralocorticoid treatment. Second, rats receiving 0.75 microgram/h 9 alpha-fluorocortisol, a mineralocorticoid and glucocorticoid agonist, respond with hypertension and cardiac fibrosis without cardiac hypertrophy. Finally, intracerebroventricular infusion of the mineralocorticoid receptor antagonist RU-28318 blocks blood pressure elevation, but not cardiac hypertrophy or fibrosis, when aldosterone is coinfused peripherally. We conclude that the myocardial fibrosis observed in response to chronic mineralocorticoid elevation and salt loading is a humorally mediated event independent of hypokalemia, hypertension, and cardiac hypertrophy. It remains to be determined whether the fibrosis observed in the presence of excess salt represents a direct (e.g., cardiac) effect of mineralocorticoid hormones or one mediated via a primary action on classical epithelial aldosterone target tissues (e.g., kidney).

摘要

之前的研究表明,饮用1.0%氯化钠溶液并连续8周输注醛固酮(0.75微克/小时)的单侧肾切除大鼠会出现高血压、心脏肥大和心脏纤维化。在本研究中,我们发现补充钾(1.0%氯化钠加0.4%氯化钾饮用溶液)既不会改变间质纤维化,也不会改变血管周围对盐皮质激素治疗的纤维化反应。其次,接受0.75微克/小时9α-氟皮质醇(一种盐皮质激素和糖皮质激素激动剂)的大鼠会出现高血压和心脏纤维化,但无心脏肥大。最后,当外周共同输注醛固酮时,脑室内输注盐皮质激素受体拮抗剂RU-28318可阻断血压升高,但不能阻断心脏肥大或纤维化。我们得出结论,慢性盐皮质激素升高和盐负荷导致的心肌纤维化是一种体液介导的事件,与低钾血症、高血压和心脏肥大无关。在盐过量情况下观察到的纤维化是盐皮质激素的直接(如对心脏)作用,还是通过对经典上皮醛固酮靶组织(如肾脏)的主要作用介导,仍有待确定。

相似文献

1
Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.实验性高盐皮质激素状态下心脏纤维化的决定因素。
Am J Physiol. 1995 Oct;269(4 Pt 1):E657-62. doi: 10.1152/ajpendo.1995.269.4.E657.
2
Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?给予盐皮质激素/盐后,糖皮质激素受体阻断会加重组织损伤吗?
Endocrinology. 2007 Oct;148(10):4829-35. doi: 10.1210/en.2007-0209. Epub 2007 Jul 19.
3
Adrenal steroids and cardiac fibrosis.肾上腺类固醇与心脏纤维化。
Steroids. 1995 Jan;60(1):133-6. doi: 10.1016/0039-128x(94)00029-c.
4
Mineralocorticoids, salt, hypertension: effects on the heart.盐皮质激素、盐与高血压:对心脏的影响
Steroids. 1996 Apr;61(4):233-5. doi: 10.1016/0039-128x(96)00020-7.
5
Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.实验性心肌肥厚和纤维化中的早期炎症反应:11β-羟基类固醇脱氢酶失活的影响
Endocrinology. 2003 Mar;144(3):1121-5. doi: 10.1210/en.2002-220926.
6
Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injury.钠/氢交换体1参与盐皮质激素/盐诱导的心脏损伤。
Hypertension. 2003 Mar;41(3):493-8. doi: 10.1161/01.HYP.0000056769.73726.E5. Epub 2003 Feb 17.
7
Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone/salt-treated rats.依普利酮而非撤用类固醇可逆转脱氧皮质酮/盐处理大鼠的心脏纤维化。
Endocrinology. 2004 Jul;145(7):3153-7. doi: 10.1210/en.2004-0005. Epub 2004 Apr 1.
8
The role of the glucocorticoid receptor in mineralocorticoid/salt-mediated cardiac fibrosis.糖皮质激素受体在盐皮质激素/盐介导的心脏纤维化中的作用。
Endocrinology. 2006 Dec;147(12):5901-6. doi: 10.1210/en.2006-0658. Epub 2006 Sep 21.
9
Maintained ENaC trafficking in aldosterone-infused rats during mineralocorticoid and glucocorticoid receptor blockade.在盐皮质激素和糖皮质激素受体阻断期间,维持醛固酮注入大鼠体内的上皮钠通道(ENaC)转运。
Am J Physiol Renal Physiol. 2007 Jan;292(1):F382-94. doi: 10.1152/ajprenal.00212.2005. Epub 2006 Aug 15.
10
Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.盐状态和阻断盐皮质激素受体对醛固酮诱导的心脏损伤的影响。
Hypertens Res. 2014 Feb;37(2):125-33. doi: 10.1038/hr.2013.124. Epub 2013 Sep 19.

引用本文的文献

1
To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.是否进行盐皮质激素受体拮抗剂(MRA)治疗?来自不同MRA对心力衰竭患者心血管健康影响的随机对照试验荟萃分析的证据
Front Cardiovasc Med. 2025 Jul 23;12:1564860. doi: 10.3389/fcvm.2025.1564860. eCollection 2025.
2
Salt and Aldosterone - Reciprocal and Combined Effects in Preclinical Models and Humans.盐和醛固酮——临床前模型和人类中的相互作用和联合效应。
Horm Metab Res. 2024 Jan;56(1):99-106. doi: 10.1055/a-2172-7228. Epub 2023 Sep 8.
3
Cardiovascular Interactions of Renin-Angiotensin-Aldosterone System Assessed by Cardiac Magnetic Resonance: The Multi-Ethnic Study of Atherosclerosis.
心脏磁共振评估的肾素-血管紧张素-醛固酮系统的心血管相互作用:动脉粥样硬化的多民族研究。
Am J Hypertens. 2023 Aug 5;36(9):517-523. doi: 10.1093/ajh/hpad050.
4
Evaluation of Mineralocorticoid Receptor Antagonism on Changes in NT-proBNP Among Persons With HIV.评估盐皮质激素受体拮抗剂对HIV感染者NT-proBNP变化的影响。
J Endocr Soc. 2021 Nov 19;6(1):bvab175. doi: 10.1210/jendso/bvab175. eCollection 2022 Jan 1.
5
Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension.盐皮质激素和血管紧张素1型受体在血管紧张素诱导的高血压中室旁核的作用。
Front Physiol. 2021 Mar 8;12:640373. doi: 10.3389/fphys.2021.640373. eCollection 2021.
6
Coronary Vasculature and Myocardial Structure in HIV: Physiologic Insights From the Renin-Angiotensin-Aldosterone System.HIV 患者的冠状动脉血管和心肌结构:肾素-血管紧张素-醛固酮系统的生理学见解。
J Clin Endocrinol Metab. 2021 Nov 19;106(12):3398-3412. doi: 10.1210/clinem/dgab112.
7
Identifying new cellular mechanisms of mineralocorticoid receptor activation in the heart.鉴定心脏中醛固酮受体激活的新细胞机制。
J Hum Hypertens. 2021 Feb;35(2):124-130. doi: 10.1038/s41371-020-0386-5. Epub 2020 Jul 30.
8
Plasma xanthine oxidase activity is related to increased sodium and left ventricular hypertrophy in resistant hypertension.血浆黄嘌呤氧化酶活性与耐药性高血压患者的钠摄入增加和左心室肥厚有关。
Free Radic Biol Med. 2019 Apr;134:343-349. doi: 10.1016/j.freeradbiomed.2019.01.029. Epub 2019 Jan 26.
9
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.难治性高血压的管理:聚焦于盐皮质激素受体拮抗剂
Vasc Health Risk Manag. 2017 Oct 16;13:403-411. doi: 10.2147/VHRM.S138599. eCollection 2017.
10
The Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature.醛固酮受体在炎症中的作用:聚焦于肾脏和血管。
Am J Nephrol. 2017;46(4):298-314. doi: 10.1159/000480652. Epub 2017 Oct 10.